Summary Slide.png (116.81 kB)

First-Line Atezolizumab for Metastatic NSCLC with high PD-L1 expression: A United States-Based Cost-Effectiveness Analysis

Download (116.81 kB)
figure
posted on 01.04.2021, 15:07 by Adis Journals on behalf of:, Ye Peng, ,Xiaohui Zeng, Liubao Peng, Qiao Liu, Lidan Yi, Xia Luo, Sini Li, Liting Wang, Shuxia Qin, Xiaomin Wan, Chongqing Tan



The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History